Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome.
Song L, Bekdash R, Morikawa K, Quejada JR, Klein AD, Aina-Badejo D, Yoshida K, Yamamoto HE, Chalan A, Yang R, Patel A, Sirabella D, Lee TM, Joseph LC, Kawano F, Warren JS, Soni RK, Morrow JP, Yazawa M.
Song L, et al. Among authors: sirabella d.
Nat Cardiovasc Res. 2022 Feb;1(2):142-156. doi: 10.1038/s44161-021-00016-2. Epub 2022 Feb 17.
Nat Cardiovasc Res. 2022.
PMID: 36051854
Free PMC article.